InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by McMinn Rachel, 首席执行官. Director active across 2 companies, notably Neurogene Inc.. Cumulatively, 7 disclosures have been logged. Breakdown: 1 buy · 3 sells. Total volume traded: €990k. Activity tracked since 22 November 2024. The latest transaction was disclosed on 26 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Rachel McMinn is the Chief Executive Officer of Neurogene Inc. She leads the company, focusing on growth strategy and innovation. Her leadership is crucial for achieving organizational goals and strengthening the market position of the firm.